Neuralink Receives Canadian Approval for Brain Implant Trials
Neuralink receives approval from Health Canada for clinical trials of a brain implant allowing paralyzed individuals to control digital devices through thought.
Clinical Trials
Read More
China’s mRNA Tumor Vaccine for Epstein-Barr Virus Approved for Clinical Trials
China approves an mRNA vaccine targeting Epstein-Barr virus positive tumors for clinical trials, marking a significant advancement in cancer immunotherapy.
Cuba Advances COVID-19 Vaccine Development with Four Candidates in Trials
Cuba accelerates COVID-19 vaccine development with four candidates in clinical trials, highlighting its scientific expertise.
Challenges in Achieving Diversity in COVID-19 Vaccine Clinical Trials
Scientists face challenges in recruiting diverse volunteers for COVID-19 vaccine trials due to historical stigma and socio-economic barriers, impacting the global fight against the pandemic.